mHealth and Home Monitoring

Table of Contents

Table of Contents

List of Figures

Executive summary

1. The challenge from welfare diseases

• 1.1 Introduction
• 1.2 Common chronic diseases
  • 1.2.1 Cardiac arrhythmia
  • 1.2.2 Hypertension
  • 1.2.3 Ischemic diseases
  • 1.2.4 Sleep apnea
  • 1.2.5 Chronic respiratory diseases
  • 1.2.6 Diabetes
  • 1.2.7 Hyperlipidemia
• 1.3 Healthcare providers and reimbursement systems by market
  • 1.3.1 Healthcare in Europe
  • 1.3.2 Healthcare in the US and Canada
  • 1.3.3 Healthcare in Asia and Australia

2. Home healthcare monitoring

• 2.1 Medical monitoring
  • 2.1.1 Cardiac monitoring
  • 2.1.2 Blood pressure monitoring
  • 2.1.3 Blood coagulation monitoring
  • 2.1.4 Sleep monitoring
  • 2.1.5 Blood oxygen level monitoring
  • 2.1.6 Breath monitoring
  • 2.1.7 Glucose monitoring
  • 2.1.8 Lipid monitoring
• 2.2 Technology trends in health monitoring
  • 2.2.1 Going digital, going wireless
  • 2.2.2 Dedicated PDAs vs general devices
  • 2.2.3 Outsourcing of health monitoring
  • 2.2.4 Distance disease management
  • 2.2.5 Frequency and volume of data to transfer
  • 2.2.6 eHealth, mHealth and telemedicine
• 2.3 Regulatory environment
  • 2.3.1 Regulatory environment in Europe
  • 2.3.2 Regulatory environment in the US
  • 2.3.3 Regulatory environment on other major markets
  • 2.3.4 International standardization

3. Physiological monitoring solution providers

• 3.1 Cardiac monitoring
  • 3.1.1 CardioNet
  • 3.1.2 LifeWatch (formerly Card Guard)
  • 3.1.3 Philips Healthcare
  • 3.1.4 Aerotel
  • 3.1.5 BioWatch Medical
  • 3.1.6 Boston Scientific
  • 3.1.7 Corventis
  • 3.1.8 eCardio
  • 3.1.9 Kiwok
  • 3.1.10 Medtronic
  • 3.1.11 Polar Electro
  • 3.1.12 SHL Telemedicine
  • 3.1.13 Sorin Group
  • 3.1.14 St Jude
  • 3.1.15 Transoma Medical
  • 3.1.16 Vitaphone
• 3.2 Blood pressure monitoring
  • 3.2.1 Omron Healthcare
  • 3.2.2 A&D Medical
  • 3.2.3 Microlife
  • 3.2.4 AViTA
  • 3.2.5 Graham Fields Health Products
  • 3.2.6 Honeywell Hommed
  • 3.2.7 IEM
  • 3.2.8 Medisana
  • 3.2.9 Rossmax
• 3.3 Coagulation monitoring
  • 3.3.1 Inverness Medical Innovations
  • 3.3.2 Thoratec
• 3.4 Sleep monitoring
  • 3.4.1 ResMed
  • 3.4.2 CareFusion
  • 3.4.3 AdActive
  • 3.4.4 BiancaMed
  • 3.4.5 Cadwell
  • 3.4.6 CleveMed
  • 3.4.7 Embla
  • 3.4.8 Kai Sensors
  • 3.4.9 Grass Technologies
• 3.5 Blood oxygen monitoring
  • 3.5.1 Covidien
  • 3.5.2 Masimo
  • 3.5.3 Nonin
  • 3.5.4 Opto Circuits
• 3.6 Air flow monitoring
  • 3.6.1 Smith' s Medical
  • 3.6.2 Clement Clarke International
  • 3.6.3 Medical Electronic Construction
  • 3.6.4 Medical International Research
  • 3.6.5 Midmark
  • 3.6.6 ndd Medizintechnik
  • 3.6.7 nSpire
  • 3.6.8 SDI Diagnostics
  • 3.6.9 Sibelmed
  • 3.6.10 Welch Allyn
• 3.7 Glucose level monitoring
  • 3.7.1 Abbott Laboratories
  • 3.7.2 Bayer Healthcare
  • 3.7.3 Johnson & Johnson
  • 3.7.4 Roche
  • 3.7.5 BodyTel
  • 3.7.6 Cardiocom
  • 3.7.7 Dexcom
  • 3.7.8 HealthPia America
• 3.8 Lipid monitoring
  • 3.8.1 CardioChek
  • 3.8.2 APEX
  • 3.8.3 Biomedix

4. Medication and equipment monitoring solution providers

• 4.1 Medication compliance monitoring
  • 4.1.1 Aardex Group
  • 4.1.2 Bang & Olufsen Medicom
  • 4.1.3 Cypak
  • 4.1.4 Information Mediary Corporation
  • 4.1.5 InforMedix
  • 4.1.6 Medic4All/Telcomed
  • 4.1.7 M-PLIFY
  • 4.1.8 Proteus Biomedical
  • 4.1.9 SimPill
  • 4.1.10 Vitality
  • 4.1.11 Vivatec
• 4.2 Integrated solution providers
  • 4.2.1 Arrowhead Electronic Healthcare
  • 4.2.2 GE Healthcare
  • 4.2.3 iMetrikus
  • 4.2.4 Invivo Data
  • 4.2.5 MedApps
  • 4.2.6 PHT
  • 4.2.7 Tunstall Group
  • 4.2.8 T+ Medical

5. Telecom and IT industry initiatives

• 5.1 Handset manufacturers
  • 5.1.1 Apple' s iPhone drives development of mHealth apps
  • 5.1.2 Lack of mHealth products for Nokia' s smartphones
  • 5.1.3 Research in Motion and Palm face challenges
• 5.2 Telecom operators
  • 5.2.1 Verizon Wireless teams with LifeWatch
  • 5.2.2 Qualcomm cancels health-oriented MVNO Lifecomm
  • 5.2.3 France Telecom' s Orange Healthcare unit aims for leadership in eHealth
  • 5.2.4 SaskTel first to launch Alcatel-Lucent' s LifeStat
  • 5.2.5 NTT DoCoMo introduces health-oriented handsets
• 5.3 IT companies
  • 5.3.1 Google Health
  • 5.3.2 Microsoft HealthVault
  • 5.3.3 Intel Health Guide
  • 5.3.4 Dossia employee health records
• 5.4 Industry associations and research institutes
  • 5.4.1 Continua Health Alliance
  • 5.4.2 The Bluetooth SIG Medical Working Group
  • 5.4.3 West Wireless Health Institute

6. Market analysis and recommendations

• 6.1 Market analysis
• 6.2 Market drivers and challenges
  • 6.2.1 An aging population
  • 6.2.2 Increasing welfare disease prevalence
  • 6.2.3 Focus on disease prevention
  • 6.2.4 Substitutes to medical monitoring
• 6.3 Potential market catalysts
  • 6.3.1 Increased monitoring during clinical trials
  • 6.3.2 Insurance companies demanding monitoring
  • 6.3.3 Non-prescribed monitoring
• 6.4 Recommendations for mobile industry players

Glossary

List of Figures

• Figure 1.1: Percentage of population diagnosed with chronic welfare diseases
• Figure 1.2: Number of people suffering from chronic welfare diseases (EU/US 2008)
• Figure 1.3: Healthcare expenditure per capita by country (US$, World 2005)
• Figure 1.4: Share of population covered by private health insurance by country
• Figure 2.1: Overview of remote ECG monitoring
• Figure 2.2: Example of blood pressure monitor from Omron Healthcare
• Figure 2.3: Example of glucose meters from Lifescan and Roche
• Figure 2.4: Examples of methods for uploading health monitoring data
• Figure 3.1: Major suppliers of physiological monitoring solutions
• Figure 3.2: Brands used by the major diabetes monitoring companies
• Figure 5.1: Companies offering HealthVault-certified products
• Figure 5.2: Intel' s Health Guide
• Figure 5.3: Selected members of the Continua Health Alliance, by industry
• Figure 6.1: Home medical monitoring market value by segment (World 2008 - 2013)